{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:44:49Z","timestamp":1751280289987,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s40291-023-00663-0","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:02:02Z","timestamp":1692205322000},"page":"741-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3664-7810","authenticated-orcid":false,"given":"Lei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hainan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zedan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaifang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingcheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Ci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"issue":"1","key":"663_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1476-4598-13-101","volume":"13","author":"H Girgis","year":"2014","unstructured":"Girgis H, et\u00a0al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer. 2014;13(1):101.","journal-title":"Mol Cancer"},{"issue":"3","key":"663_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor A, et\u00a0al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519\u201330.","journal-title":"Eur Urol"},{"issue":"1","key":"663_CR3","doi-asserted-by":"publisher","first-page":"15698","DOI":"10.1038\/s41598-017-15922-4","volume":"7","author":"MCS Wong","year":"2017","unstructured":"Wong MCS, et\u00a0al. Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Sci Rep. 2017;7(1):15698.","journal-title":"Sci Rep"},{"issue":"8","key":"663_CR4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","volume":"7","author":"Y-F Gu","year":"2017","unstructured":"Gu Y-F, et\u00a0al. Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor GradeBap1 and Pbrm1 loss drives tumor grade in ccRCC. Cancer Discov. 2017;7(8):900\u201317.","journal-title":"Cancer Discov"},{"issue":"7","key":"663_CR5","first-page":"1198","volume":"80","author":"RM Bukowski","year":"1997","unstructured":"Bukowski RM. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer Interdiscip Int J Am Cancer Soc. 1997;80(7):1198\u2013220.","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"issue":"2","key":"663_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, et\u00a0al. Global cancer statistics, 2012. CA Cancer J Clinicians. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clinicians"},{"key":"663_CR7","doi-asserted-by":"crossref","unstructured":"Pilar and Laguna, Re: axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial. J Urol. 2019.","DOI":"10.1097\/JU.0000000000000268"},{"issue":"9","key":"663_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1200\/JCO.2017.74.2627","volume":"36","author":"KD Courtney","year":"2018","unstructured":"Courtney KD, et\u00a0al. Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2\u03b1 antagonist in patients with previously treated advanced clear cell renal cell carcinoma. J Clin Oncol. 2018;36(9):867.","journal-title":"J Clin Oncol"},{"issue":"3","key":"663_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/2159-8290.CD-19-0837","volume":"10","author":"L Hu","year":"2020","unstructured":"Hu L, et\u00a0al. TBK1 Is a synthetic lethal target in cancer with VHL lossTBK1 is a novel therapeutic target in cancer with VHL loss. Cancer Discov. 2020;10(3):460\u201375.","journal-title":"Cancer Discov"},{"issue":"6","key":"663_CR10","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0022-5347(01)66674-6","volume":"154","author":"MM Walther","year":"1995","unstructured":"Walther MM, et\u00a0al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995;154(6):2010\u20135.","journal-title":"J Urol"},{"key":"663_CR11","doi-asserted-by":"crossref","unstructured":"Nielsen SM, et\u00a0al. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. American Society of Clinical Oncology; 2016.","DOI":"10.1200\/JCO.2015.65.6140"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejrad.2018.01.026","volume":"101","author":"M Czarniecki","year":"2018","unstructured":"Czarniecki M, et\u00a0al. Imaging findings of hereditary renal tumors, a review of what the radiologist should know. Eur J Radiol. 2018;101:8\u201316.","journal-title":"Eur J Radiol"},{"issue":"3","key":"663_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","volume":"165","author":"JC Herring","year":"2001","unstructured":"Herring JC, et\u00a0al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol. 2001;165(3):777\u201381.","journal-title":"J Urol"},{"issue":"2","key":"663_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/1078-0432.CCR-18-0841","volume":"25","author":"JH Yim","year":"2019","unstructured":"Yim JH, et\u00a0al. Identification of tissue-specific DNA methylation signatures for thyroid nodule diagnostics. Clin Cancer Res. 2019;25(2):544\u201351.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"663_CR15","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-14-2820","volume":"21","author":"TJ Galloway","year":"2015","unstructured":"Galloway TJ, et\u00a0al. A phase I study of CUDC-101, a multitarget inhibitor of HDACs, EGFR, and HER2, in combination with chemoradiation in patients with head and neck squamous cell carcinomaCUDC-101 plus cisplatin-radiotherapy for HNSCC. Clin Cancer Res. 2015;21(7):1566\u201373.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"663_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/cancers14051163","volume":"14","author":"MA Iqbal","year":"2022","unstructured":"Iqbal MA, et\u00a0al. Preliminary study on the sequencing of whole genomic methylation and transcriptome-related genes in thyroid carcinoma. Cancers. 2022;14(5):1163.","journal-title":"Cancers"},{"issue":"22","key":"663_CR17","doi-asserted-by":"publisher","first-page":"13557","DOI":"10.1093\/nar\/gku885","volume":"42","author":"A Suzuki","year":"2014","unstructured":"Suzuki A, et\u00a0al. Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines. Nucleic Acids Res. 2014;42(22):13557\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"663_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0235-x","volume":"12","author":"BN Lasseigne","year":"2014","unstructured":"Lasseigne BN, et\u00a0al. DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC Med. 2014;12(1):1\u201310.","journal-title":"BMC Med"},{"issue":"8","key":"663_CR19","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/annonc\/mdp577","volume":"21","author":"Y Kawai","year":"2010","unstructured":"Kawai Y, et\u00a0al. Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma. Ann Oncol. 2010;21(8):1612\u20137.","journal-title":"Ann Oncol"},{"issue":"12","key":"663_CR20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/onc.2010.525","volume":"30","author":"MR Morris","year":"2011","unstructured":"Morris MR, et\u00a0al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene. 2011;30(12):1390\u2013401.","journal-title":"Oncogene"},{"issue":"6b","key":"663_CR21","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1111\/j.1582-4934.2008.00515.x","volume":"12","author":"I Buysschaert","year":"2008","unstructured":"Buysschaert I, et\u00a0al. Genetics, epigenetics and pharmaco-(epi) genomics in angiogenesis. J Cell Mol Med. 2008;12(6b):2533\u201351.","journal-title":"J Cell Mol Med"},{"issue":"24","key":"663_CR22","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1158\/1078-0432.CCR-09-2131","volume":"15","author":"AC Young","year":"2009","unstructured":"Young AC, et\u00a0al. Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma VHL and sporadic renal cell carcinoma. Clin Cancer Res. 2009;15(24):7582\u201392.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"663_CR23","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1038\/s41598-018-21524-5","volume":"8","author":"CM Robinson","year":"2018","unstructured":"Robinson CM, et\u00a0al. Consequences of VHL loss on global DNA methylome. Sci Rep. 2018;8(1):3313.","journal-title":"Sci Rep"},{"issue":"6","key":"663_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.rbmo.2016.09.006","volume":"33","author":"YJ Menezo","year":"2016","unstructured":"Menezo YJ, et\u00a0al. Oxidative stress and alterations in DNA methylation: two sides of the same coin in reproduction. Reprod Biomed Online. 2016;33(6):668\u201383.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"663_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-021-01208-0","volume":"13","author":"Y Mao","year":"2021","unstructured":"Mao Y, et\u00a0al. Genome-wide methylation and expression analyses reveal the epigenetic landscape of immune-related diseases for tobacco smoking. Clin Epigenet. 2021;13(1):1\u201314.","journal-title":"Clin Epigenet"},{"issue":"9","key":"663_CR26","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1101\/gr.136838.111","volume":"22","author":"C Cheng","year":"2012","unstructured":"Cheng C, et\u00a0al. Understanding transcriptional regulation by integrative analysis of transcription factor binding data. Genome Res. 2012;22(9):1658\u201367.","journal-title":"Genome Res"},{"issue":"3","key":"663_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.scijus.2015.01.005","volume":"55","author":"SC Ip","year":"2015","unstructured":"Ip SC, Lin S-W, Lai K-M. An evaluation of the performance of five extraction methods: chelex\u00ae 100, QIAamp\u00ae DNA blood mini kit, QIAamp\u00ae DNA investigator kit, QIAsymphony\u00ae DNA Investigator\u00ae kit and DNA IQ\u2122. Sci Justice. 2015;55(3):200\u20138.","journal-title":"Sci Justice"},{"issue":"1","key":"663_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07882-8","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et\u00a0al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1\u201310.","journal-title":"Nat Commun"},{"issue":"1","key":"663_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-5-66","volume":"5","author":"BL Petrella","year":"2006","unstructured":"Petrella BL, Brinckerhoff CE. Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase. Mol Cancer. 2006;5(1):1\u201314.","journal-title":"Mol Cancer"},{"issue":"12","key":"663_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-014-0117-z","volume":"6","author":"Q Liu","year":"2014","unstructured":"Liu Q, et\u00a0al. Transcriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity. Genome Med. 2014;6(12):1\u201312.","journal-title":"Genome Med"},{"issue":"8","key":"663_CR31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/15592294.2021.1971372","volume":"17","author":"AV Artemov","year":"2021","unstructured":"Artemov AV, et\u00a0al. An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer. Epigenetics. 2021;17(8):894\u2013905.","journal-title":"Epigenetics"},{"issue":"8","key":"663_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/15592294.2021.1971372","volume":"17","author":"AV Artemov","year":"2022","unstructured":"Artemov AV, et\u00a0al. An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer. Epigenetics. 2022;17(8):894\u2013905.","journal-title":"Epigenetics"},{"issue":"9","key":"663_CR33","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1101\/gr.260497.119","volume":"30","author":"S Aganezov","year":"2020","unstructured":"Aganezov S, et\u00a0al. Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. Genome Res. 2020;30(9):1258\u201373.","journal-title":"Genome Res"},{"issue":"2","key":"663_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.298","volume":"41","author":"RA Irizarry","year":"2009","unstructured":"Irizarry RA, et\u00a0al. Genome-wide methylation analysis of human colon cancer reveals similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178.","journal-title":"Nat Genet"},{"issue":"1","key":"663_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0514-6","volume":"15","author":"M Nojima","year":"2016","unstructured":"Nojima M, et\u00a0al. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma. Mol Cancer. 2016;15(1):1\u201315.","journal-title":"Mol Cancer"},{"issue":"3","key":"663_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1158\/2159-8290.CD-11-0098","volume":"1","author":"C Shen","year":"2011","unstructured":"Shen C, et\u00a0al. Genetic and functional studies implicate HIF1\u03b1 as a 14q kidney cancer suppressor GeneHIF1\u03b1 Is a 14q kidney cancer suppressor gene. Cancer Discov. 2011;1(3):222\u201335.","journal-title":"Cancer Discov"},{"issue":"36","key":"663_CR37","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1200\/JCO.2018.79.2549","volume":"36","author":"JJ Hsieh","year":"2018","unstructured":"Hsieh JJ, et\u00a0al. Chromosome 3p loss\u2013orchestrated VHL, HIF, and epigenetic deregulation in clear cell renal cell carcinoma. J Clin Oncol. 2018;36(36):3533.","journal-title":"J Clin Oncol"},{"issue":"1","key":"663_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4161\/auto.26534","volume":"10","author":"G Wan","year":"2014","unstructured":"Wan G, et\u00a0al. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway. Autophagy. 2014;10(1):70\u20139.","journal-title":"Autophagy"},{"issue":"21","key":"663_CR39","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1158\/1078-0432.CCR-10-0820","volume":"16","author":"B Li","year":"2010","unstructured":"Li B, et\u00a0al. Orally administered particulate \u03b2-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer particulate \u03b2-glucan elicits antitumor T-cell responses. Clin Cancer Res. 2010;16(21):5153\u201364.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"663_CR40","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1084\/jem.20120944","volume":"209","author":"J Ni","year":"2012","unstructured":"Ni J, et\u00a0al. Sustained effector function of IL-12\/15\/18-preactivated NK cells against established tumors. J Exp Med. 2012;209(13):2351\u201365.","journal-title":"J Exp Med"},{"issue":"7791","key":"663_CR41","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/d41586-019-03943-0","volume":"577","author":"TC Bruno","year":"2020","unstructured":"Bruno TC. B cells to the forefront of immunotherapy. Nature. 2020;577(7791):474.","journal-title":"Nature"},{"issue":"7","key":"663_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000114","volume":"6","author":"PO Brown","year":"2009","unstructured":"Brown PO, Palmer C. The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med. 2009;6(7): e1000114.","journal-title":"PLoS Med"},{"issue":"4","key":"663_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccr.2013.08.027","volume":"24","author":"K Pozo","year":"2013","unstructured":"Pozo K, et\u00a0al. The role of Cdk5 in neuroendocrine thyroid cancer. Cancer Cell. 2013;24(4):499\u2013511.","journal-title":"Cancer Cell"},{"issue":"12","key":"663_CR44","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/annonc\/mdn527","volume":"19","author":"A Brandt","year":"2008","unstructured":"Brandt A, et\u00a0al. Age of onset in familial cancer. Ann Oncol. 2008;19(12):2084\u20138.","journal-title":"Ann Oncol"},{"issue":"11","key":"663_CR45","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/ajg.2012.288","volume":"107","author":"MA Anderson","year":"2012","unstructured":"Anderson MA, et\u00a0al. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol. 2012;107(11):1730.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"663_CR46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","volume":"32","author":"B Shuch","year":"2014","unstructured":"Shuch B, et\u00a0al. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014;32(5):431.","journal-title":"J Clin Oncol"},{"key":"663_CR47","doi-asserted-by":"crossref","unstructured":"Wang J, et\u00a0al. Natural history of Von Hippel\u2013Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study. J Cancer Res Clin Oncol. 2021:1\u201311.","DOI":"10.21203\/rs.3.rs-675576\/v1"},{"issue":"4","key":"663_CR48","first-page":"1455","volume":"53","author":"C-H Gattolliat","year":"2018","unstructured":"Gattolliat C-H, et\u00a0al. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease. Int J Oncol. 2018;53(4):1455\u201368.","journal-title":"Int J Oncol"},{"issue":"11","key":"663_CR49","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1158\/0008-5472.CAN-09-0146","volume":"69","author":"R Beroukhim","year":"2009","unstructured":"Beroukhim R, et\u00a0al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Can Res. 2009;69(11):4674\u201381.","journal-title":"Can Res"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-023-00663-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T10:06:16Z","timestamp":1697882776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-023-00663-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s40291-023-00663-0","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"type":"print","value":"1177-1062"},{"type":"electronic","value":"1179-2000"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"2 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the National High-Level Hospital Clinical Research Funding (High-Quality Clinical Research Project of Peking University First Hospital, 2022CR75), National Natural Science Foundation of China (no. 82141103; 82172617; 82172665; 81872081), Scientific Research Seed Fund of Peking University First Hospital (2021SF01; 2023SF40), Capital\u2019s Funds for Health Improvement and Research (2022-2-4074), and Sino-Russian Mathematics Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data that support the findings of this study are available in the Genome Sequence Archive for Human (GSA-Human) ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors Lei Li, Hainan Bao, Yawei Xu, Wuping Yang, Zedan Zhang, Kaifang Ma, Kenan Zhang, Jingcheng Zhou, Yanqing Gong, Weimin Ci, and Kan Gong declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval for the study was granted by the ethics committee of Peking University First Hospital, with the assigned number IRB00001052-18004. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Verbal informed consent was obtained from the patients for their anonymized information to be published in this article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"K.G. and W.M.C. were responsible for the overall planning of the study. L.L., H.N.B., and Y.W.X. mainly directed bioinformatics analysis and wrote the paper. W.P.Y., Z.D.Z., and K.F.M. were mainly responsible for the compilation of experimental data. K.N.Z. collected and preserved the samples. J.C.Z. and Y.Q.G. mainly polished the article. All authors contributed critical review of the manuscript, revisions, and have approved its submission.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}